| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers B > Headlines for Bank of Montreal > News item |
Bank of Montreal plans buffered bullish two-year notes on biotech ETF
New York, Sept. 4 – Bank of Montreal plans to price 0% buffered bullish enhanced return notes due Sept. 29, 2017 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
The payout at maturity will be par plus 150% of any fund gain, up to a maximum payout of 19.5%.
Investors will receive par if the fund falls by up to 10% and will lose 1% for each 1% decline beyond 10%.
BMO Capital Markets Corp. is the agent.
The notes will price on Sept. 25 and settle on Sept. 30.
The Cusip number is 06366R2A2.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.